Oxford University Press

SHERPA: Yellow

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Mellinghoff
    Mellinghoff
  4. Shuman
    Shuman
  5. Rosenblum
    Rosenblum
  6. Dunkel
    Dunkel
  7. Karajannis
    Karajannis
  8. Saltz
    Saltz
  9. Souweidane
    Souweidane
  10. Panageas
    Panageas

Groups

  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)
  7. Department of Pathology and Laboratory Medicine (415)
  8. Gastrointestinal Oncology Service (386)
  9. Genitourinary Oncology Service (367)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2107)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (92)
  5. Editorial (84)
  6. Guidelines (36)
  7. Correspondence (26)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (10)
Groups
  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Stewart Shuman (88)
  6. Marc Rosenblum (87)

More People

Years
  1. 2025 (105)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1670)
  2. Neuro-Oncology (846)
  3. JNCI: Journal of the National Cancer Institute (485)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (138)
  6. American Journal of Clinical Pathology (106)

More Publications

Results (4652)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An exploratory analysis looking at the association of germline coding mutations with impaired development and adaptive behavior function in pediatric medulloblastoma patients treated on Head Start 4
    Meeting Abstract

    Fleming, J. L.; Sells, B. E.; Bell, E. H.; McElroy, J. P.; Webb, A.; Zhao, Y.; Graham, R. T.; Guo, Y.; Liu, T.; Timmers, C.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Feasibility of acute slice culture-single cell sequencing drug screening as a tool to select therapy for children with relapsed brain tumors
    Meeting Abstract

    Gampel, B.; Szalontay, L.; Zhao, W.; Garvin, J.; Sethi, C.; Stark, E.; Sims, P.; Canoll, P.; Zacharoulis, S.
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Phase II study of axitinib in patients with neurofibromatosis type 2 and progressive vestibular schwannomas
    Meeting Abstract

    Phadnis, S.; Hagiwara, M.; Yaffe, A.; Mitchell, C.; Nicolaides, T.; Akshintala, S.; Hochman, T.; Goldberg, J.; Allen, J.; Karajannis, M.
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Machine-learning inference may predict quality of life subgroups of adamantinomatous craniopharyngioma
    Meeting Abstract

    Hengartner, A. C.; Prince, E.; Staulcup, S.; Vijmasi, T.; Souweidane, M.; Jackson, E. M.; Johnston, J. M.; Anderson, R. C. E.; Naftel, R. P.; Grant, G.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Quantitative MR imaging features associated with unique transcriptional characteristics in pediatric adamantinomatous craniopharyngioma: A potential guide for therapy
    Meeting Abstract

    Mirsky, D.; Prince, E.; Staulcup, S.; Hengartner, A.; Vijmasi, T.; Johnston, J.; Massimi, L.; Anderson, R.; Souweidane, M.; Naftel, R.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Outcome of BRAF V600e pediatric gliomas treated with targeted BRAF inhibition
    Meeting Abstract

    Nobre, L.; Zapotocky, M.; Ramaswamy, V.; Ryall, S.; Bennet, J.; Alderete, D.; Guill, J. B.; Baroni, L.; Bartels, U.; Bavle, A.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Entrectinib in recurrent or refractory solid tumors including primary CNS tumors: Updated data in children and adolescents
    Meeting Abstract

    Robinson, G.; Desai, A.; Basu, E.; Foster, J.; Gauvain, K.; Sabnis, A.; Shusterman, S.; Macy, M.; Mease, L.; Yoon, J.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Response assessment in pediatric high-grade glioma: Recommendations from the Response Assessment in Pediatric Neuro-Oncology Working Group
    Meeting Abstract

    Erker, C.; Tamrazi, B.; Poussaint, T. Y.; Mueller, S.; Mata-Mbemba, D.; Franceschi, E.; Brandes, A. A.; Rao, A.; Haworth, K. B.; Wen, P. Y.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Response assessment in diffuse intrinsic pontine glioma (DIPG): Recommendations from the Response Assessment in Pediatric Neuro-Oncology Committee
    Meeting Abstract

    Cooney, T.; Cohen, K. J.; Guimaraes, C. V.; Dhall, G.; Leach, J.; Massimino, M.; Erbetta, A.; Chiapparini, L.; Malbari, F.; Kramer, K.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • A phase II re-treatment study of selumetinib for recurrent or progressive pediatric low-grade glioma (PLGG): A Pediatric Brain Tumor Consortium (PBTC) study
    Meeting Abstract

    Fangusaro, J.; Onar-Thomas, A.; Wu, S.; Poussaint, T. Y.; Packer, R.; Kilburn, L.; Qaddoumi, I.; Dhall, G.; Pollack, I. F.; Lenzen, A.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save